While the narrative around GLP-1 medications often centers on weight loss, increased energy, and greater physical activity, emerging research suggests a more complex reality. A recent study indicates a potential disconnect between weight reduction and activity levels for individuals using these drugs, a finding that warrants careful consideration for anyone undergoing or contemplating such treatment.
Study Findings on Physical Activity
A real-world investigation, presented at the Endocrine Society’s annual meeting, examined the physical activity patterns of over 700 adults with obesity initiating GLP-1 therapy. By integrating data from Fitbit devices with electronic health records, researchers were able to quantify daily step counts and minutes of moderate-to-vigorous physical activity before and after the commencement of treatment.
The analysis revealed a notable decrease in daily steps, falling from an average of 5,047 to 4,487, representing a reduction of 560 steps. Similarly, moderate-to-vigorous physical activity declined from 27.9 minutes per day to 22.2 minutes. The most significant drops in activity were observed among men and individuals experiencing musculoskeletal pain.
Essentially, participants were achieving weight loss while simultaneously reducing their physical movement.
Reasons for Reduced Activity on GLP-1s
This observed decline in physical activity is not entirely unexpected, considering the physiological effects of GLP-1 medications. These drugs function by suppressing appetite and slowing the rate at which the stomach empties, leading to a substantial reduction in caloric intake. This caloric deficit can manifest as fatigue, nausea, and diminished energy levels, all of which can impede consistent physical activity.
Furthermore, the study’s finding that individuals with musculoskeletal pain showed the most pronounced activity decreases highlights a critical factor. Pre-existing joint pain and physical discomfort are already significant barriers to exercise; the side effects associated with GLP-1 therapy can exacerbate these challenges. When feeling physically depleted, engaging in physical activity often becomes a low priority.
An additional, more subtle dynamic may also be at play. The potent effectiveness of GLP-1 medications in promoting weight loss might lead some individuals to perceive less necessity for exercise, as if the medication is solely responsible for the progress. However, this perspective overlooks a crucial component of overall health.
Weight Loss is Not Synonymous with Health
Weight loss is frequently viewed as the ultimate goal, with the assumption that improved health will automatically follow. This perspective is fundamentally limited.
When weight reduction occurs without concurrent maintenance of physical activity, a significant portion of the lost mass may not be fat but muscle. A comprehensive review from 2024 indicated that GLP-1 drugs can contribute to a substantial loss of lean muscle mass, estimated at around 10% during treatment. This rate is comparable to or even exceeds age-related muscle loss over many years, potentially amounting to approximately 6 kilograms (13 pounds) of muscle mass reduction.
The American Heart Association has emphasized that exercise yields health benefits that extend beyond weight reduction. These benefits include improvements in blood pressure, insulin sensitivity, cholesterol profiles, and cardiorespiratory fitness, regardless of changes on the scale. Thus, the body’s health can improve irrespective of weight fluctuations.
These medications are effective for weight loss, but if physical activity diminishes concurrently, individuals may miss out on the distinct health advantages conferred by regular movement. The true value of exercise lies in its positive impact on cardiovascular health, metabolic function, and muscle integrity.
The preservation of muscle mass is particularly vital in this context. The AHA acknowledges that weight loss achieved through calorie restriction alone often results in the loss of muscle alongside fat, a phenomenon mirrored when GLP-1 medications suppress appetite. Exercise, especially resistance training, is indispensable for retaining muscle mass.
In essence, physical activity should not be considered an optional health enhancement but a fundamental requirement.
Integrating Intentional Movement on GLP-1 Therapy
Maintaining muscle mass is paramount for long-term health and vitality, especially for individuals utilizing GLP-1 medications. Incorporating regular physical activity into one’s routine can seem challenging, but a structured approach can yield significant benefits.
- Prioritize Resistance Training: Engaging in strength training exercises is the most effective method for preserving lean muscle mass during weight loss. Even two to three sessions per week can contribute significantly to muscle maintenance. For those new to strength training, bodyweight exercises, resistance bands, or structured programs offer accessible starting points.
- Make Daily Movement Intentional: The study highlighted a decrease in overall daily step counts among GLP-1 users. Re-establishing a baseline level of activity does not necessitate formal gym visits. Daily walks, choosing stairs over elevators, or incorporating short bursts of movement throughout the day (“exercise snacks”) all contribute positively. It’s crucial to view physical activity as an essential daily component rather than an activity reserved for periods of surplus energy.
- Address Side Effects Constructively: Experiencing nausea, fatigue, or reduced appetite during the initial phase of GLP-1 therapy is common and warrants a temporary reduction in exercise intensity. However, as the body adapts, it is important to gradually reintroduce structured physical activity. Even 10 to 15 minutes of exercise can have a meaningful impact on long-term health outcomes.
- Complement Movement with Adequate Protein: Sufficient protein intake, combined with exercise, plays a critical role in preserving lean muscle mass during weight loss. Ensuring adequate protein consumption at each meal, particularly when appetite is suppressed, helps safeguard muscle tissue.
Conclusion
GLP-1 medications are most effective when physical activity is an integral part of the treatment plan, rather than an afterthought. The current research indicates that a decline in activity is a common pattern among users of these medications, and the long-term health implications of losing muscle mass concurrently with fat are significant. For individuals seeking to preserve muscle while on GLP-1 therapy, proactively integrating movement back into their daily routines is essential.
creatine tone+
Lean muscle meets smarter metabolism.*
★ ★ ★ ★ ★ ★ ★ ★ ★ ★
(6)
Business Style Takeaway: For executives utilizing GLP-1 medications, maintaining physical activity, particularly resistance training, is crucial for preserving muscle mass and overall metabolic health. This approach ensures that weight loss translates into sustained vitality and functional strength, rather than compromised physical resilience, thereby supporting long-term cognitive function and productivity.
Information compiled from materials : www.mindbodygreen.com